| Product NDC: | 0039-0023 |
| Proprietary Name: | Claforan |
| Non Proprietary Name: | cefotaxime sodium |
| Active Ingredient(s): | 1 g/1 & nbsp; cefotaxime sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0039-0023 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062659 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090622 |
| Package NDC: | 0039-0023-50 |
| Package Description: | 50 VIAL in 1 PACKAGE (0039-0023-50) > 1 INJECTION in 1 VIAL |
| NDC Code | 0039-0023-50 |
| Proprietary Name | Claforan |
| Package Description | 50 VIAL in 1 PACKAGE (0039-0023-50) > 1 INJECTION in 1 VIAL |
| Product NDC | 0039-0023 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefotaxime sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20090622 |
| Marketing Category Name | ANDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | CEFOTAXIME SODIUM |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |